{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:19:46Z","timestamp":1694621986360},"reference-count":7,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2004,1]]},"abstract":"ABSTRACT<\/jats:title>\n \n Testing of susceptibility to penicillin G by E-test and sequencing of an internal fragment of the\n penA<\/jats:italic>\n gene were done for 43 meningococcal strains. Those strains for which the MIC was \u22650.094 \u03bcg\/ml showed mosaic alleles, so 0.094 \u03bcg\/ml is suggested as the penicillin G intermediate breakpoint when E-test is used.\n <\/jats:p>","DOI":"10.1128\/aac.48.1.358-359.2004","type":"journal-article","created":{"date-parts":[[2003,12,24]],"date-time":"2003-12-24T02:03:22Z","timestamp":1072231402000},"page":"358-359","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["Sequencing of\n Neisseria meningitidis penA<\/i>\n Gene: the Key to Success in Defining Penicillin G Breakpoints"],"prefix":"10.1128","volume":"48","author":[{"given":"Luisa","family":"Arreaza","sequence":"first","affiliation":[{"name":"Reference Laboratory for Meningococci, National Center of Microbiology, Institute of Health Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Salcedo","sequence":"additional","affiliation":[{"name":"Reference Laboratory for Meningococci, National Center of Microbiology, Institute of Health Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bele\u0301n","family":"Alcala\u0301","sequence":"additional","affiliation":[{"name":"Reference Laboratory for Meningococci, National Center of Microbiology, Institute of Health Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari\u0301a Jose\u0301","family":"Uri\u0301a","sequence":"additional","affiliation":[{"name":"Reference Laboratory for Meningococci, National Center of Microbiology, Institute of Health Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Abad","sequence":"additional","affiliation":[{"name":"Reference Laboratory for Meningococci, National Center of Microbiology, Institute of Health Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roci\u0301o","family":"Enri\u0301quez","sequence":"additional","affiliation":[{"name":"Reference Laboratory for Meningococci, National Center of Microbiology, Institute of Health Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio A.","family":"Va\u0301zquez","sequence":"additional","affiliation":[{"name":"Reference Laboratory for Meningococci, National Center of Microbiology, Institute of Health Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"107","volume":"67","year":"2001","unstructured":"Arreaza, L., and J. A. V\u00e1zquez. 2001. Molecular approach for the study of penicillin resistance in Neisseria meningitidis. Methods Mol. Med.67:107-119.","journal-title":"Methods Mol. Med."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1705-1707.2000"},{"key":"e_1_3_2_4_2","first-page":"89","volume":"67","year":"2001","unstructured":"Block, C. 2001. Antibiotic susceptibility testing. Methods Mol. Med.67:89-106.","journal-title":"Methods Mol. Med."},{"key":"e_1_3_2_5_2","unstructured":"National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing. Eleventh Informational Supplement. NCCLS document M100-S11. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/313599"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00182388"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00013542-200101000-00005"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.1.358-359.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.1.358-359.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:02:11Z","timestamp":1645466531000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.48.1.358-359.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1128\/AAC.48.1.358-359.2004"],"URL":"https:\/\/doi.org\/10.1128\/aac.48.1.358-359.2004","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"2003-06-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-09-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}